共 255 条
[1]
Jemal A(2003)Cancer statistics, 2003 CA Cancer J Clin 53 5-26
[2]
Murray T(2003)Review article: colorectal cancer chemotherapy Aliment Pharmacol Ther 18 683-692
[3]
Samuels A(2004)Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer Br J Cancer 91 1420-1424
[4]
Ghafoor A(2005)Rapamycin: an anti-cancer immunosuppressant? Crit Rev Oncol Hematol 56 47-60
[5]
Ward E(2007)Phosphorylation of ribosomal p70 S6 kinase and rapamycin sensitivity in human colorectal cancer Cancer Lett 251 105-113
[6]
Thun MJ(2002)Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor Nat Med 8 128-135
[7]
Gill S(2005)Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF Blood 105 4463-4469
[8]
Thomas RR(2004)Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapy Clin Cancer Res 10 1843-1852
[9]
Goldberg RM(2002)Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy Cancer Res 62 7291-7297
[10]
Chan S(2002)Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells Cancer Res 62 6141-6145